SPARC and colorectal carcinoma: Based on these initial results suggesting that a recombinant protein containing only the N-terminus domain of SPARC was capable of diminishing cell viability in not only sensitive CRC cells, but also in their chemo-resistant counterparts, we decided to validate this observation by mutating the N-terminus domain, and found that the mutant forms no longer promoted a chemosensitizing effect.